RICE Pharmaceuticals
1017.506.937 · rovalta.com · 25/09/2026
RICE Pharmaceuticals
Company — Normal situation.
Financial year 2026 · Closed on 26/02/2026
Overview
Identity
Source · BCE/KBORICE Pharmaceuticals is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 1017.506.937
- Legal form
- Private limited company
- Contributed capital
- 10,00 €
- Latest accounts
- 26/02/2026
- Average workforce
- 0,0 ETP
Financials
Source · NBB, 2 filingsTrend over 2 financial years
| 2026 | 2025 | ||
|---|---|---|---|
| Income statement | |||
| Gross margin | 0 € | +100% | -24,6 k € |
| EBITDA | 0 € | +100% | -127 k € |
| Operating result | 0 € | +100% | -127 k € |
| Net result | -321,4 € | +99.8% | -134,3 k € |
| Balance sheet | |||
| Equity | -134,6 k € | -0.2% | -134,2 k € |
| Total assets | 5,2 k € | +38.4% | 3,8 k € |
| Debts | 132,5 k € | +1.1% | 131,1 k € |
| Other | |||
| Workforce | 0,0 ETP | 0,0 ETP | |
Board of directors
Source · NBB, accounts to 26/02/20261 active
Active mandates
Financials
Full financial information
Source · NBB| 2026 | 2025 | |
|---|---|---|
| Type of account | Abridged model | Abridged model |
| Start of the financial year | 01/01/2026 | 17/12/2024 |
| Closing of the financial year | 26/02/2026 | 31/12/2025 |
| Length of the financial year | 2 months | 13 months |
| Filing date | 25/03/2026 | 23/03/2026 |
| General meeting | 26/02/2026 | 26/02/2026 |
| Currency of the financial year | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 2 filingsValuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 26/02/20261 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2026Annual accounts 2026-321,4 €↑
- 2026Name changeRICE Pharmaceuticals in vereffening
- 2025Annual accounts 2025-134,3 k €
- 2025Name changeRICE Pharmaceuticals